Inicia sesión Registrate Mi Biblioteca biblioteca abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.

163045 ARTíCULOS , VIENDO DEL 61 AL 75

PUBMED

Biofilm Biology to Brain Health: Harnessing Microbial Wisdom to Uncover Amyloid Dissociating Bifunctional Nano Chaperones for Alzheimer's Therapeutics

Randhawa S, Saini TC, Bathla M, Teji N, Acharya A.

ACS Chem Neurosci. 2025 May 7;16(9):1647-1661. doi: 10.1021/acschemneuro.4c00868. Epub 2025 Apr 18.

0

0

0

PUBMED

Dual single nucleotide polymorphisms typing of apolipoprotein E gene based on double restriction endonuclease with lambda exonuclease and triple helix molecular switch assistance

Lin G, Liang W, He Q, Wang Y, Yang X.

Biosens Bioelectron. 2025 Jun 15;278:117365. doi: 10.1016/j.bios.2025.117365. Epub 2025 Mar 11.

0

0

0

PUBMED

Physical activity changes during midlife link to brain integrity and amyloid burden

Akinci M, Aguilar-Domínguez P, Palpatzis E, Shekari M, García-Prat M, Deulofeu C, Fauria K, García-Aymerich J, Gispert JD, Suárez-Calvet M, Grau-Rivera O, Sánchez-Benavides G, Arenaza-Urquijo EM; ALFA

Alzheimers Dement. 2025 May;21(5):e70007. doi: 10.1002/alz.70007.

0

0

0

PUBMED

Resistance exercise to reduce risk of falls in people with Alzheimer's disease: a randomised clinical trial

Cámara-Calmaestra R, Martínez-Amat A, Aibar-Almazán A, Hita-Contreras F, de Miguel-Hernando N, Rodríguez-Almagro D, Jiménez-García JD, Achalandabaso-Ochoa A.

Physiotherapy. 2025 Mar;126:101440. doi: 10.1016/j.physio.2024.101440. Epub 2024 Oct 28.

0

0

0

PUBMED

T-regulatory cells and extracellular vesicles in Alzheimer's disease: New therapeutic concepts and hypotheses

De Sousa RAL, Mendes BF.

Brain Res. 2025 Mar 1;1850:149393. doi: 10.1016/j.brainres.2024.149393. Epub 2024 Dec 11.

0

0

0

PUBMED

Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer's disease

Azam U, Naseer MM, Rochais C.

Eur J Med Chem. 2025 Mar 15;286:117277. doi: 10.1016/j.ejmech.2025.117277. Epub 2025 Jan 17.

0

0

0

PUBMED

Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research

Smith EE, Phillips NA, Feldman HH, Borrie M, Ganesh A, Henri-Bhargava A, Desmarais P, Frank A, Badhwar A, Barlow L, Bartha R, Best S, Bethell J, Bhangu J, Black SE, Bocti C, Bronskill SE, Burhan AM, C

J Prev Alzheimers Dis. 2025 Mar;12(3):100068. doi: 10.1016/j.tjpad.2025.100068. Epub 2025 Jan 31.

0

0

0

PUBMED

Protocol for an intergenerational randomized controlled trial to enhance physical activity in older adults at risk for Alzheimer's disease

Walker CS, Noriega de la Colina AE, Li L, Boulanger C, Thovinakere N, Noly-Gandon A, Barnoin G, Bennett M, Caplan J, Côté L, Elbaz S, Bao SFK, Kara R, Lavoie N, Nguyen M, Otaner F, Pallett-Wiesel H, P

J Prev Alzheimers Dis. 2025 Mar;12(3):100039. doi: 10.1016/j.tjpad.2024.100039. Epub 2025 Jan 9.

0

0

0

PUBMED

Innovations in noninvasive sensory stimulation treatments to combat Alzheimer's disease

Park JM, Tsai LH.

PLoS Biol. 2025 Feb 28;23(2):e3003046. doi: 10.1371/journal.pbio.3003046. eCollection 2025 Feb.

0

0

0

PUBMED

Perivascular brain clearance as a therapeutic target in cerebral amyloid angiopathy and Alzheimer's disease

Bonnar O, Eyre B, van Veluw SJ.

Neurotherapeutics. 2025 Apr;22(3):e00535. doi: 10.1016/j.neurot.2025.e00535. Epub 2025 Jan 30.

0

0

0

PUBMED

Targeting hypoxia-related pathobiology in Alzheimer's disease: strategies for prevention and treatment

Sharma V, Verma R, Singh TG.

Mol Biol Rep. 2025 Apr 23;52(1):416. doi: 10.1007/s11033-025-10520-4.

0

0

0

PUBMED

Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer's disease

Qiu Y, Jacobs DM, Messer K, Salmon DP, Wellington CL, Stukas S, Revta C, Brewer JB, Léger GC, Askew B, Donahue L, Kaplita S, Coric V, Qureshi IA, Feldman HH; Alzheimer’s Disease Cooperative Study T2 P

Alzheimers Res Ther. 2025 May 2;17(1):97. doi: 10.1186/s13195-025-01745-3.

0

0

0

PUBMED

Evaluation of neuroprotective role of benfotiamine in Alzheimer's disease model: A randomized control study

Mallika B, Sudha K, Massand A, Murlimanju BV, Sonal G, Neelam MP, Sowndarya K.

Clin Ter. 2025 Mar-Apr;176(2):127-135. doi: 10.7417/CT.2025.5195.

0

0

0

PUBMED

Repurposing drugs: promising therapeutic approach against Alzheimer's disease

Pattanaik S, Ghose A, Pakeeraiah K, Paidesetty SK, Prusty SK, Sahu PK.

Ageing Res Rev. 2025 Apr;106:102698. doi: 10.1016/j.arr.2025.102698. Epub 2025 Feb 22.

0

0

0

PUBMED

Harnessing marine resources for Alzheimer's therapy: A review integrating bioactivity and molecular docking

Khalid H, Mohamed H, Eltoukhy A, Saeed MT, Song Y.

Eur J Pharmacol. 2025 Jun 15;997:177611. doi: 10.1016/j.ejphar.2025.177611. Epub 2025 Apr 9.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neuroacademy